SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-135055
Filing Date
2018-04-26
Accepted
2018-04-26 16:50:55
Documents
7
Effectiveness Date
2018-04-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A d566466ddefa14a.htm DEFA14A 36399
2 GRAPHIC g56646612.jpg GRAPHIC 2585
3 GRAPHIC g566466dsp4snap4.jpg GRAPHIC 1403
4 GRAPHIC g566466dsp7snap1.jpg GRAPHIC 1408
5 GRAPHIC g566466g33p26.jpg GRAPHIC 3423
6 GRAPHIC g566466g55q60.jpg GRAPHIC 3438
7 GRAPHIC g566466g97m83.jpg GRAPHIC 16028
  Complete submission text file 0001193125-18-135055.txt   77340
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36783 | Film No.: 18779334
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences